Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life

Cell Transplantation

Volumn 21, Issue SUPPL. 1, 2012, Pages

  Sharma, Alok ^a   Gokulchandran, Nandini ^a   Chopra, Guneet ^a   Kulkarni, Pooja ^a   Lohia, Mamta ^a   Badhe, Prerna ^a   Jacob, V C ^a  

^a Surana Sethia Hospital and Research Centre   (India)

Author keywords

Adult stem cells; Autologous; Bone marrow; Cerebral palsy; Mononuclear cells; Muscular dystrophy; Spinal cord injury

Indexed keywords

ADOLESCENT; ARTHROGRYPOSIS; ARTICLE; AUTISM; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN ELECTROPHYSIOLOGY; BRAIN INJURY; BROOKE SCALE; CEREBRAL PALSY; CHILD; CONTROLLED STUDY; ELECTROMYOGRAPHY; FOLLOW UP; FUNCTIONAL INDEPENDENCE MEASURE; GIANT AXONAL NEUROPATHY; HEAD INJURY; HUMAN; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MUSCLE STRENGTH; MUSCLE TONE; MUSCULAR DYSTROPHY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RETT SYNDROME; SCHOOL CHILD; SPASTICITY; SPEECH; SPINAL CORD INJURY; SPINAL MUSCULAR ATROPHY; VIGNOS SCALE;

BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; HUMANS; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES; QUALITY OF LIFE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84930473990     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X633798     Document Type: Article

References (22)

1. Brooke, M. H.; Griggs, R. C.; Mendell, J. R.; Fenichel, G. M.; Shumate, J. B.; Pellegrino, R. J. Clinical trial in Duchenne dystrophy. The design of the protocol. Muscle Nerve 4:186-197; 1981.
2. Callera, F.; do Nascimento, R. X. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: A preliminary safety study. Exp. Hematol. 34(2):130-131; 2006.
3. Carlson, R. V.; Boyd, K. M.; Webb, D. J. The revision of the Declaration of Helsinki: Past, present and future. Br. J. Clin. Pharmacol. 57:695-713; 2004.
4. Edwards, S. Abnormal tone and movement as a result of neurologic impairment considerations for treatment. In: Edwards, S., ed. Neurological physiotherapy: A problem solving approach. New Delhi, India: Churchill Livingstone; 2002:89-111.
5. Fabel, K.; Wolf, S. A.; Ehninger, D.; Babu, H.; Galicia, P. L.; Kempermann, G. Additive effects of physical exercise and environmental enrichment on adult hippocampal neurogenesis in mice. Front. Neurosci. 3:50; 2009.
6. Geffner, L. F.; Santacruz, P.; Izurieta, M.; Flor, L.; Maldonado, B.; Auad, A. H.; Montenegro, X.; Gonzalez, R.; Silva, F. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant. 17:1277-1293; 2008.
7. Gogel, S.; Gubernatorand, M.; Minger, S. L. Progress and prospects: Stem cells and neurological diseases. Gene Ther. 18:1-6; 2011.
8. Granger, C. V.; Hamilton, B. B.; Linacre, J. M.; Heinemann, A. W.; Wright, B. D. Performance profiles of the functional independence measure. Am. J. Phys. Med. Rehabil. 72:84-89; 1993.
9. Hombach-Klonisch, S.; Panigrahi, S.; Rashedi, I. Adult stem cells and their trans-differentiation potential-per-spectives and therapeutic applications. J. Mol. Med. 86(12):1301-1314; 2008.
10. Joy Singh, A. K.; Roy, S. Stem cells in PMR practices. IJPMR 19(1):1-5; 2008.
11. Kim, S. U.; de Vellis, J. Stem cell-based cell therapy in neurological diseases: A review. J. Neurosci. Res. 87(10): 2183-2200; 2009.
12. Kumar, A. A.; Kumar, S. R.; Narayanan, R.; Arul, K.; Baskaran, M. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp. Clin. Transplant. 7(4):241-248; 2009.
13. Miyan, J. A.; Zendah, M.; Mashayekhi, F.; Owen-Lynch, P. J. Cerebrospinal fluid supports viability and proliferation of cortical cells in vitro, mirroring in vivo development. Cerebrospinal Fluid Res. 3:2; 2006.
14. Petit, I.; Szyper-Kravitz, M.; Nagle, A. R.; Lahav, M.; Peled, A.; Habler, L.; Ponomaryov, T.; Taichman, R. S.; Arenzana-Seisdedos, F.; Fujii, N.; Sandbank, J.; Zipori, D.; Lapidot, T. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3:687-694; 2002.
15. Ramirez, F.; Steenblock, D. A.; Payne, A. G.; Darnall, L. Umbilical cord stem cell therapy for cerebral palsy. Med. Hypotheses Res. 3:679-686; 2006.
16. Seledtsov, V. I.; Kafanova, M. Y.; Rabinovich, S. S.; Poveshchenko, O. V.; Kashchenko, E. A.; Fel'de, M. A.; Samarin, D. M.; Seledtsova, G. V.; Kozlov, V. A. Cell therapy of cerebral palsy. Bull. Exp. Biol. Med. 139(4): 499-503; 2005.
17. Sharma, A.; Gokulchandran, N. Mechanism of action. In: Sharma, A.; Gokulchnadran, N., eds. Stem cell therapy in neurological disorders. Mumbai, India: Surekha Press; 2010:61-69.
18. Skuk, D.; Roy, B.; Goulet, M.; Chapdelaine, P.; Bouchard, J. P.; Roy, R.; Dugre, F. J.; Lachance, J. G.; Deschenes, L.; Helene, S.; Sylvain, M.; Tremblay, J. P. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol. Ther. 9:475-482; 2004.
19. Sykova, E.; Homola, A.; Mazanec, R.; Lachmann, H.; Konradova, S. L.; Kobylka, P.; Padr, R.; Neuwirth, J.; Komrska, V.; Vavra, V.; Stulík, J.; Bojar, M. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant. 15:675-687; 2006.
20. Vandervelde, S.; van Luyn, M. J.; Tio, R. A.; Harmsen, M. C. Signaling factors in stem cell mediated repair of infarcted myocardium. J. Mol. Cell. Cardiol. 39(2):363-376; 2005.
21. Vignos, P. J.; Archibald, K. C. Maintenance of ambulation in childhood muscular dystrophy. J. Chronic Dis. 12:273-290; 1960.
22. Yang, X. F.; Xu, Y. F.; Zhang, Y. B.; Wang, H. M.; Lu, N. W.; Wu, Y. X.; Lu, X.; Cui, J. P.; Shan, H.; Yan, Y.; Zhou, J. X. Functional improvement of patients with progressive muscular dystrophy by bone marrow and umbilical cord blood mesenchymal stem cell transplantations. Zhonghua Yi Xue Za Zhi 89(36):2552-2556; 2009.